Expression of CDK7 correlates with molecular subtypes and predicts clinical outcomes in breast cancer

BACKGROUND: Cyclin-dependent kinase 7 (CDK7) belongs to CDK family, which is involved in transcriptional activity and cell cycle progression. Recent studies have suggested that CDK7 inhibitor is effective in the treatment of breast cancer, whereas, the efficacy of antitumor response varies significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lin, Zhu, Chengjun, Jin, Juan, Wang, Xin, Yu, Lingyue, Guan, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799258/
https://www.ncbi.nlm.nih.gov/pubmed/35116400
http://dx.doi.org/10.21037/tcr-20-2911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799258/
https://www.ncbi.nlm.nih.gov/pubmed/35116400
http://dx.doi.org/10.21037/tcr-20-2911

Ejemplares similares